Data included in this review indicated that the prevalence of reported co-administration was higher in 2022 than in 2021, signaling an increasing trend in the co-administration of influenza and the BNT162B2 vaccine.
← all excerpts
Co-Administration of BNT162b2 COVID-19 and Influenza Vaccines in Adults: A Global Systematic Review.
1
—
—